Editor's choice

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
Francesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, Fabrizio Conti

Annals of the Rheumatic Diseases May 2020, 79 (5) 666-667; DOI: 10.1136/annrheumdis-2020-217367
Mitochondrial DNA haplogroups influence the risk of incident knee osteoarthritis in OAI and CHECK cohorts. A meta-analysis and functional study
Mercedes Fernández-Moreno, Angel Soto-Hermida, María E Vázquez-Mosquera, Estefanía Cortés-Pereira, Sara Relaño, Tamara Hermida-Gómez, Sonia Pértega, Natividad Oreiro-Villar, Carlos Fernández-López, Rafael Garesse, Francisco J Blanco, Ignacio Rego-Pérez

Annals of the Rheumatic Diseases Jun 2017, 76 (6) 1114-1122; DOI: 10.1136/annrheumdis-2016-210131
Functional genomics of autoimmune diseases
Akari Suzuki, Matteo Maurizio Guerrini, Kazuhiko Yamamoto

Annals of the Rheumatic Diseases Jun 2021, 80 (6) 689-697; DOI: 10.1136/annrheumdis-2019-216794
Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study
S Clockaerts, G J V M Van Osch, Y M Bastiaansen-Jenniskens, J A N Verhaar, F Van Glabbeek, J B Van Meurs, H J M Kerkhof, A Hofman, B H Ch Stricker, S M Bierma-Zeinstra

Annals of the Rheumatic Diseases May 2012, 71 (5) 642-647; DOI: 10.1136/annrheumdis-2011-200092
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
J T Merrill, R F van Vollenhoven, J P Buyon, R A Furie, W Stohl, M Morgan-Cox, C Dickson, P W Anderson, C Lee, P-Y Berclaz, T Dörner

Annals of the Rheumatic Diseases Feb 2016, 75 (2) 332-340; DOI: 10.1136/annrheumdis-2015-207654
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
Dae Hyun Yoo, Pawel Hrycaj, Pedro Miranda, Edgar Ramiterre, Mariusz Piotrowski, Sergii Shevchuk, Volodymyr Kovalenko, Nenad Prodanovic, Mauricio Abello-Banfi, Sergio Gutierrez-Ureña, Luis Morales-Olazabal, Michael Tee, Renato Jimenez, Omid Zamani, Sang Joon Lee, HoUng Kim, Won Park, Ulf Müller-Ladner

Annals of the Rheumatic Diseases Oct 2013, 72 (10) 1613-1620; DOI: 10.1136/annrheumdis-2012-203090
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
Alexis Ogdie, YiDing Yu, Kevin Haynes, Thorvardur Jon Love, Samantha Maliha, Yihui Jiang, Andrea B Troxel, Sean Hennessy, Steven E Kimmel, David J Margolis, Hyon Choi, Nehal N Mehta, Joel M Gelfand

Annals of the Rheumatic Diseases Feb 2015, 74 (2) 326-332; DOI: 10.1136/annrheumdis-2014-205675
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
Viktor Molander, Hannah Bower, Thomas Frisell, Johan Askling

Annals of the Rheumatic Diseases Feb 2021, 80 (2) 169-175; DOI: 10.1136/annrheumdis-2020-218419
Platelets in rheumatoid arthritis: exploring the anti-inflammatory and antithrombotic potential of TNF inhibitors
Armen Yuri Gasparyan, George D Kitas

Annals of the Rheumatic Diseases Aug 2016, 75 (8) 1426-1427; DOI: 10.1136/annrheumdis-2015-208720
COVID-19 cytokine storm: what is in a name?
Peter A Nigrovic

Annals of the Rheumatic Diseases Jan 2021, 80 (1) 3-5; DOI: 10.1136/annrheumdis-2020-219448

Main menu

Editor's choice

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Editor's choice

Pages